Search
-
News
Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.
… Monday, July 28, 2014 Summary Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC , a cancer-causing gene that has remained elusive until now. Many of the most effective cancer therapies available today have been developed
-
Video
Al Roker reflects on his own experience with doctors, and discusses the mistrust that some people feel towards the health care system.
… Al Roker reflects on his own experience with doctors, and discusses the mistrust that some people feel towards the health care system.
-
News
Researchers learn how prostate cancer cells change their type to survive treatment.
… Friday, September 2, 2022 Cancer cells are adept at developing ways to evade treatments. For example, prostate cancer prostate cancer becomes resistant to hormone therapy hormone therapy by changing a protein called the androgen receptor (AR), which plays a key role in determining cellular identity.
-
Neurosurgeon
I am a neurosurgeon who specializes in treating tumors of the brain and spine, as well as tumors that have spread, or metastasized, to the brain and spine from other parts of the body.
… Neurosurgeon Job Title Instructor I am a neurosurgeon who specializes in treating tumors of the brain and spine , as well as tumors that have spread, or metastasized, to the brain and spine from other parts of the body. My training at leading centers in the United States and France has given me a global
-
Neurosurgeon
Soy neurocirujano especializado en el tratamiento de tumores del cerebro y la columna vertebral, así como de tumores que se han diseminado o han hecho metástasis al cerebro y la columna desde otras partes del cuerpo.
… Neurosurgeon Job Title Instructor Soy neurocirujano especializado en el tratamiento de tumores del cerebro y la columna vertebral , así como de tumores que se han diseminado o han hecho metástasis al cerebro y la columna desde otras partes del cuerpo. Gracias a mi formación en centros líderes en Estados
-
Eligibility requirements for residents’ and fellows’ appointments at Memorial Hospital’s training programs.
… Applicants must satisfy one of the following to be eligible for appointment to Memorial Hospital training programs: Graduates from an approved or recognized medical school, school of osteopathy, school of dentistry, Doctoral program that prepares students for careers in professional Psychology or Laboratory
-
Office of Entrepreneurship and Commercialization
Alexandra (Alex) Buga is a Licensing Manager in the Office of Technology Development.
… Job Title Licensing Manager Alexandra (Alex) Buga is a Licensing Manager in the Office of Technology Development. She manages the licensing of Memorial Sloan Kettering’s medical device technologies and aesthestics portfolio. She is also responsible for the administration of MSK’s Technology Development
-
Event
… The Spirituality Group at MSK explores the benefits and challenges of spirituality for people before, during, and after cancer treatment. It is a dedicated space to discuss spirituality openly, exchange personal experiences, and share spiritual practices. This monthly group is led by multifaith chaplains
-
News
By identifying mutations found in a person’s cancer, this blood test can help doctors tailor treatments to those most likely to benefit.
… Monday, March 23, 2020 Summary In a study published March 23 , scientists at Memorial Sloan Kettering reported that a blood test called a liquid biopsy can identify mutations responsible for resistance to a new class of drugs called PI3K inhibitors. These medicines were recently approved for treating
-
News
Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.
… Monday, March 13, 2006 The below press release is from Cancer Cell and is for a study published in the March issue of Cancer Cell. Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted